Company intelligence / Profile preview

Zhejiang Jolly Pharmaceutical Co., Ltd.

Huzhou, Zhejiang Province, Chinazuoli.com ↗

Ownership: Private
Employees: ~2687
Development stage: Commercial

Overview

The company has multiple approved products in the Chinese market, including their flagship Wuling capsule which received first-class Chinese medicine certification in 1998. They are expanding into neurological disease treatments through a partnership with Lingyi Biotech.

Therapeutic areas: Men's HealthPulmonologyEndocrinologyGastroenterologyNeurologyWomen's Health
Modalities: Chinese medicinal productsherbal medicinepolymers
Industry: Biotech

Drug pipeline

5 assets

wulingshen

4 more assets in the full pipeline.

Partnerships

Lingyi (Hangzhou) Biotechnology

Beyond the preview

Go deeper on Zhejiang Jolly Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Jolly Pharmaceutical Co., Ltd..